Delivery Order SPE2DB20D1100-SPE2DB25FA0N6

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Duloxetine HCL DR 40 MG capsules in 30-count packages, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $1,579.93 and an ultimate completion date of January 27, 2025. The award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,566,824,824 units of Duloxetine HCL DR 40 mg capsules, with a ceiling value of $1,046.01. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA, which provides a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of 4,562,967,827 units of Duloxetine HCL DR 60 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,070.83. It is a delivery order contract with a firm fixed price pricing type. The ultimate completion date is December 4, 2023. This contract is not associated with a set-aside program. AmerisourceBergen Drug Corp is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Duloxetine HCL DR 40 mg capsules. The contract has a firm fixed price of $1,356.00 and an ultimate completion date of August 23, 2024. It is a delivery order contract and does not have a set-aside designation. Amerisourcebergen, through its Corporate Office Division, is a significant supplier of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver Duloxetine HCL DR 40 mg capsules. The contract is a delivery order with a firm fixed price of $1,342.68 and an ultimate completion date of December 20, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Duloxetine HCL DR 60 mg capsules in quantities of 1,000 to the Defense Logistics Agency (DLA). The contract, valued at $1,754.23, was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm-fixed-price delivery order with a completion date of November 20, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Duloxetine Hydrochloride Delayed-Release 40 mg capsules. The delivery order, valued at $1,039.68, is under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that has a ceiling value of up to $999,999,999 through December 2025. This contract does not have a set-aside designation and is for a Firm Fixed Price...
This federal contract award, valued at $7,143.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,824,965 units of Duloxetine HCL DR 60 MG capsules. This is a Firm Fixed Price Delivery Order contract with a completion date of January 3, 2025. The award is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of Duloxetine HCL DR 60 MG capsules to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $5,310.82 and is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 10, 2024 and was awarded on October 9, 2024. It is not designated as a set-aside contract. AmerisourceBergen, through its extensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,961.25 firm fixed-price delivery order is for the supply of 4566789424 - Duloxetine HCL DR 40 MG capsules, with a completion date of December 24, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA0N6
    Delivery Order

This federal contract award is for the delivery of Duloxetine HCL DR 40 mg capsules, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,838.53 and is a firm-fixed-price delivery order. The award is not associated with a set-aside program. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract will run through January 15, 2025.

Generated 4/21/25, 3:40 AM